Enzymatic activation of indolequinone-substituted 5-fluorodeoxyuridine prodrugs in hypoxic cells

Bioorg Med Chem Lett. 2019 Jun 1;29(11):1304-1307. doi: 10.1016/j.bmcl.2019.04.003. Epub 2019 Apr 4.

Abstract

Among the various enzymes, reductases that catalyze one-electron reduction are involved in the selective activation of functional compounds or materials in hypoxia, which is one of the well-known pathophysiological characteristics of solid tumors. Enzymatic one-electron reduction has been recognized as a useful reaction that can be applied in the design of tumor hypoxia-targeting drugs. In this report, we characterized the enzymatic reaction of 5-fluorodeoxyuridine (FdUrd) prodrug bearing an indolequinone unit (IQ-FdUrd), which is a substrate of reductases. IQ-FdUrd was activated to release FdUrd under hypoxic conditions after treatment with cytochrome NADPH P450 reductase. We also confirmed that IQ-FdUrd showed selective cytotoxicity in hypoxic tumor cells.

Keywords: Enzymatic activation; Prodrug; Reductase; Tumor hypoxia.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Hypoxia / drug effects*
  • Dose-Response Relationship, Drug
  • Enzyme Activation
  • Floxuridine / chemistry
  • Floxuridine / metabolism
  • Floxuridine / pharmacology*
  • Humans
  • Indolequinones / chemistry
  • Indolequinones / metabolism
  • Indolequinones / pharmacology*
  • Molecular Structure
  • NADP / metabolism
  • NADPH-Ferrihemoprotein Reductase / metabolism*
  • Prodrugs / chemistry
  • Prodrugs / metabolism
  • Prodrugs / pharmacology*
  • Structure-Activity Relationship

Substances

  • Indolequinones
  • Prodrugs
  • Floxuridine
  • NADP
  • NADPH-Ferrihemoprotein Reductase